Biohub

@biohub.org

Combining frontier AI & frontier biology to help scientists cure or prevent disease

🎉 Congrats to Scott Fraser, Biohub’s President of Dynamic Imaging, on receiving the Microscopy Society of America’s Distinguished Scientist Award - Biological Sciences, in recognition of his transformative contributions in bioimaging and molecular analysis!

Bild

🚨 New preprint: We reprocessed 77k zebrafish RNA-seq datasets from across the global research community and found hidden viruses in 10% of them—including a fish virus whose proteins are 91% identical to human Influenza B—then built a generalizable pipeline. bit.ly/4vxFF72

Bild

7.5M people in the U.S. live with psoriasis. Many still struggle despite treatment. Our team combined AI + CRISPR to find overlooked biological pathways — then tested an existing asthma drug. It worked. This is frontier AI and frontier biology working together. 🧬 Learn more: bit.ly/44QSiyW

A Genome-Wide CRISPR Screen Reveals New Psoriasis Targets

Biohub researchers combined a genome-wide CRISPR screen with AI to uncover an unexpected psoriasis drug target: the receptor for oxytocin.

bit.ly

🎉Congrats to the Remoscope team, 1st place winner of the Medical Device category of the Nebius AI Discovery Awards! Developed at Biohub, Remoscope is an AI-powered diagnostic platform that can rapidly image and analyze blood and other biological fluids to diagnose disease.

Three men sitting at a table hold a large prize check for $100,000 at the AI Discovery Awards 2026 event, with other attendees visible in the background.

What happens when physicists turn their tools on living systems? That's the question at the heart of the Physics of Life Symposium—and this year marks its fifth edition. Submit an abstract or register to attend by Aug. 14: bit.ly/4xJIPH7

Bild

The 2nd Chicago BioEngineering Conference (CBEC) is back — Sept. 17–18 in downtown Chicago! 🧬 Omics. Bioelectronics. AI × bio. A stellar speaker lineup. Two days of science that matters. Space is limited → register now: bit.ly/4vqlXLj

Promotional card for the 2nd Chicago BioEngineering Conference (CBEC), September 17–18, 2026, at the Sheraton Grand Chicago Riverwalk

Cryo-ET gives unparalleled views of cellular structures, but targeted sample preparation by cryo-FIB milling has been a constraint. No longer! A new workflow yields close to 100% targeting success for centrioles & other small structures. Read the preprint ⤵️ www.biorxiv.org/content/10.6...

Diagram of FIB-SEM with integrated fluorescence microscope alongside cryo lamella micrograph and 3D segmentation highlighting targeted centrioles

“The laser phase plate has the highest continuous light intensity in the solar system, outside of the inner regions of the Sun,” says physicist Holger Müller. Learn more about this landmark achievement in microscopy in @cenmag.bsky.social: cen.acs.org/analytical-c...

15 years, flawless mirrors, and the brightest laser in the world: How physicists brought phase contrast to cryo-EM

Phase contrast enables structures of smaller proteins, could drive in-cell proteomics

cen.acs.org

In a series of 3 papers and preprints, we’re thrilled to share with you the working laser phase plate. In collaboration with research led by Holger Müller at UC Berkeley, this is a huge innovation in imaging to make small and faint objects inside cells visible. bit.ly/4vK9LVn

Waves of laser light coming from four different directions and meeting in the middle brightly inside the cavity of the laser phase plate

Better vitrification = better cryo-ET. We've opened an RFA for two-year grants to advance vitrification techniques for biological samples—welcoming applications from researchers in heat transfer, cryogenics, and materials science. Apply here: bit.ly/4uip6eJ

Proteins are the machinery of life. Billions of their sequences have been cataloged—but the biology behind most is still unknown. Today we're releasing ESMFold2, ESMC and ESM Atlas to help change that. Open source, open to every scientist. biohub.ai/esm/protein

Inflammation drives nearly every major disease—cancer, heart disease, and autoimmune conditions. Yet we've never been able to watch it progress in living tissue. We're funding 15 projects to build real-time molecular tools to change that. Learn more ➡️ bit.ly/4wFDJej

Bild